EAM Global Investors’s iRadimed IRMD Stock Holding History

EAM Global Investors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-42,885	Closed	-$1.92M	–	220
2022 Q1	$1.92M	Buy	+42,885	New	+$1.98M	0.35%	146
2019 Q1	–	Sell	-47,855	Closed	-$1.17M	–	142
2018 Q4	$1.17M	Buy	47,855 +7,255	+18%	+$195K	0.64%	81
2018 Q3	$1.51M	Buy	+40,600	New	+$1.1M	0.61%	68

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM Global Investors's IRMD Position: Q2 2022 in Review

EAM Global Investors sold out of iRadimed (IRMD) in Q2 2022, closing a stake of 42,885 shares — an estimated $1.92M sold.

EAM Global Investors first reported a position in IRMD in Q3 2018 and held it in 3 quarters. The position peaked at $1.92M in Q1 2022. 90 funds tracked by Wall St. Rank hold IRMD as of Q2 2022.

EAM Global Investors reported no remaining iRadimed position as of Q2 2022 after selling out during the quarter.
EAM Global Investors sold 42,885 iRadimed shares in Q2 2022, an estimated $1.92M.
EAM Global Investors first reported a position in iRadimed in Q3 2018 and held it in 3 quarters.
EAM Global Investors's iRadimed position peaked at $1.92M in Q1 2022.
90 funds tracked by Wall St. Rank held iRadimed as of Q2 2022.

Based on EAM Global Investors's 13F filing for Q2 2022, filed 12 Aug 2022.